CMO Zojwalla Naseem sold 269,509 shares for $7,530,147.84 across 4 sales, reducing stake by 98.4% at unprofitable firm.
Zojwalla Naseem, Chief Medical Officer of Olema Pharmaceuticals, executed 4 separate sales totaling 269,509 shares for $7,530,147.84 between December 19–23, 2025, at prices ranging from $27.66 to $28.93 (blended average $27.94). Post-transaction holdings dropped to 4,488 shares, representing a 98.4% reduction in his position from 273,997 shares held prior. This near-complete liquidation occurs as the company faces material headwinds: Olema reported net income of $-42,217,000.00 for its most recent full fiscal year, making it unprofitable. The company's stock is currently trading at $27.67, down 22.8% from its 52-week high of $35.83. The concentration and scale of this exit—divesting nearly the entire stake—stands in sharp contrast to the stock's 30-day (+19.4%) and 90-day (+231.4%) gains, which would otherwise suggest near-term momentum.